Erik Glocker1, Bodo Grimbacher. 1. Department of Immunology and Molecular Pathology, Royal Free Hospital & University College London, Pond Street, London, UK.
Abstract
PURPOSE OF REVIEW: To give an overview on the clinical spectrum and the molecular background of host defence against Candida. RECENT FINDINGS: For many decades the molecular causes and the pathogenesis for an increased susceptibility to Candida - and fungal infections in general - have been elusive. In 2009 and 2010 interesting reports on the genetic background and the pathomechanisms involved in chronic mucocutaneous candidiasis (CMC) have been published. SUMMARY: The susceptibility to recurrent Candida infections can be a monogenetic Mendelian trait. The sensing of Candida cell wall components and the consecutive intracellular signalling in myeloid cells via CARD9, but also the role of Th17 cells and their cytokines take centre stage in the human host defence against Candida.
PURPOSE OF REVIEW: To give an overview on the clinical spectrum and the molecular background of host defence against Candida. RECENT FINDINGS: For many decades the molecular causes and the pathogenesis for an increased susceptibility to Candida - and fungal infections in general - have been elusive. In 2009 and 2010 interesting reports on the genetic background and the pathomechanisms involved in chronic mucocutaneous candidiasis (CMC) have been published. SUMMARY: The susceptibility to recurrent Candida infections can be a monogenetic Mendelian trait. The sensing of Candida cell wall components and the consecutive intracellular signalling in myeloid cells via CARD9, but also the role of Th17 cells and their cytokines take centre stage in the human host defence against Candida.
Authors: Anna R Huppler; Natasha Whibley; Carol A Woolford; Erin E Childs; Jie He; Partha S Biswas; Mandy J McGeachy; Aaron P Mitchell; Sarah L Gaffen Journal: Infect Immun Date: 2015-07-06 Impact factor: 3.441
Authors: Heather R Conti; Vincent M Bruno; Erin E Childs; Sean Daugherty; Joseph P Hunter; Bemnet G Mengesha; Danielle L Saevig; Matthew R Hendricks; Bianca M Coleman; Lucas Brane; Norma Solis; J Agustin Cruz; Akash H Verma; Abhishek V Garg; Amy G Hise; Jonathan P Richardson; Julian R Naglik; Scott G Filler; Jay K Kolls; Satrajit Sinha; Sarah L Gaffen Journal: Cell Host Microbe Date: 2016-10-27 Impact factor: 21.023
Authors: Felix E Y Aggor; Timothy J Break; Giraldina Trevejo-Nuñez; Natasha Whibley; Bianca M Coleman; Rachel D Bailey; Daniel H Kaplan; Julian R Naglik; Wei Shan; Amol C Shetty; Carrie McCracken; Scott K Durum; Partha S Biswas; Vincent M Bruno; Jay K Kolls; Michail S Lionakis; Sarah L Gaffen Journal: Sci Immunol Date: 2020-06-05
Authors: Natasha Whibley; Elaine Tritto; Elisabetta Traggiai; Frank Kolbinger; Pierre Moulin; Dominique Brees; Bianca M Coleman; Anna J Mamo; Abhishek V Garg; Jillian R Jaycox; Ulrich Siebenlist; Michael Kammüller; Sarah L Gaffen Journal: J Leukoc Biol Date: 2016-01-04 Impact factor: 4.962
Authors: Magda Carneiro-Sampaio; Dewton Moraes-Vasconcelos; Cristina M Kokron; Cristina M A Jacob; Myrthes Toledo-Barros; Mayra B Dorna; Letícia A Watanabe; Ana Karolina B B Marinho; Ana Paula Moschione Castro; Antonio C Pastorino; Clóvis Artur A Silva; Maurício D Ferreira; Luiz V Rizzo; Jorge E Kalil; Alberto J S Duarte Journal: J Clin Immunol Date: 2013-01-29 Impact factor: 8.317